Pepe, Martino <br/><br/>
Time-dependent benefits of pre-treatment with new oral P2Y  [electronic resource] 

 -  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions  03 2019 
 - 592-601 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1522-726X 
<br/><br/><label>Standard No.: </label>10.1002/ccd.27863  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Blood Platelets--drug effects<br/>Coronary Angiography<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Percutaneous Coronary Intervention--adverse effects<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Prasugrel Hydrochloride--administration & dosage<br/>Purinergic P2Y Receptor Antagonists--administration & dosage<br/>Receptors, Purinergic P2Y12--blood<br/>Risk Assessment<br/>Risk Factors<br/>ST Elevation Myocardial Infarction--diagnostic imaging<br/>Ticagrelor--administration & dosage<br/>Time Factors<br/>Time-to-Treatment<br/>Treatment Outcome